💳 CREDIT / DEBIT CARD PAYMENTS ARE TEMPORARILY DISABLED due to a technical issue. You can still pay with Interac e-Transfer, PayPal or Bitcoin. We'll let you know as soon as cards are back.

BACK TO COLLECTION
RETATRUTIDE vial

99.482%

REPORTED PURITY

COA

SAMPLE REPORT

CANADA

DISPATCH

● IN STOCK

METABOLIC RESEARCH

VIEW COA →

RETATRUTIDE

30MG · LYOPHILIZED

Retatrutide is a triple receptor agonist (GLP-1, GIP, glucagon) investigated in laboratory metabolic-research settings.

A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.

C$200.01

Use code WELCOME15 for 15% OFF at checkout

BULK PRICING AVAILABLE10 VIALS / BOX · 50% OFF

Save more with box purchases. Add 9 more to unlock 50% off this vial.

Wholesale pricing available for schools, clinics, and repeat customers. Request a quote →

RECONSTITUTION & PROTOCOL

Full Guide Provided After Purchase

A complete reconstitution and protocol guide is included in the box with every order — printed for clean bench-side reference.

PURITY
≥99.3%
CAS NUMBER
2381089-83-2
APPEARANCE
Lyophilized white powder
SHELF LIFE
24 months unopened. 60 days reconstituted (refrigerated).
STORAGE
Store at 2–8°C, protected from light. Long-term: -20°C.
RECONSTITUTION
Reconstitute with bacteriostatic water (0.9% benzyl alcohol). Full protocol included in the box.
QUANTITY

Same product only: 3–4 vials save 10%; 5–9 save 15%. Discount codes still work on these tiers. 10+ vials get wholesale 50% off, without codes.

1

QUALITY VERIFIED

PREMIUM PACKAGING

DISCREET SHIPPING

FOR RESEARCH USE ONLY. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Sold for laboratory and research purposes only. Buyer must be 18+.
🇨🇦 Canada Fulfillment Available🇵🇭 Philippines Fulfillment AvailableThird-Party Tested

SECURE CHECKOUT

Encrypted payments & private order details

RESEARCH-GRADE QUALITY

≥99% HPLC purity across the catalog

THIRD-PARTY TESTED

Independently verified by Janoshik Analytical

DISCREET SHIPPING

Sealed, unbranded, tracked worldwide

GLOBAL FULFILLMENT NETWORK

Global Fulfillment Network

Fast, secure, and discreet fulfillment through our Canada and Philippines distribution network.

Canada FulfillmentPhilippines FulfillmentWorldwide DeliveryDiscreet Packaging

RESEARCH FOCUS

Explore RETATRUTIDE

Retatrutide is a triple receptor agonist (GLP-1, GIP, glucagon) investigated in laboratory metabolic-research settings.

A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.

For laboratory investigation only. Research findings do not establish safety or effectiveness for personal use. Not for human or animal consumption.

RETATRUTIDE FirstLabs product image

COMPOUND

RETATRUTIDE

VIAL SIZE

30MG

WHY FIRSTLABS PH

Not all peptides are equal.

WHAT YOU GET

FIRSTLABS

TYPICAL

Published third-party lab reports

—

Listed purity: ≥99.3%

—

Ships from Canada

—

Clear research-only labeling

—

Real people answering your questions

—

Open documentation

Published laboratory reports are available to review before ordering. Confirm the compound, vial size and batch with FirstLabs.

Discreet fulfillment

Canada and Philippines fulfillment options, with shipping details available before you complete checkout.

Clear research labeling

Compound identity, vial size and handling information are listed for laboratory purchasers. These are not medicines for personal use.

LAB EVIDENCE

Read the report. Check the batch.

Documentation matters more than a badge.

A report verifies only the sample described—not every vial size or shipment. Confirm which documentation applies to your order. Analysis and reported dates are not manufacture or expiry dates.

Retatrutide 30mg · 96.97%

Freedom Diagnostics · Aug 30, 2026 (reported)

Lot / batch: RET30-003 · Measured 10.82 mg

NET CONTENT BELOW LABEL. Identity confirmed by LC-MS and purity 96.97% by HPLC-UV, but Net Content measured 10.82 mg against a 30 mg label claim (~36%). This report documents lot RET30-003 only and is not evidence for another lot.

View flagged report

Retatrutide 30mg · 99.482%

Janoshik Analytical · Mar 17, 2026 (analysis)

Lot / batch: Task #121829 · Measured 33.05 mg

View exact COA
  • Match the compound name and vial size.
  • Check the batch identifier, test date and laboratory.
  • Read identity, content and purity results together.
  • A purity result alone does not establish sterility or safety for use.

STORAGE & HANDLING

Details for your laboratory.

Storage
Store at 2–8°C, protected from light. Long-term: -20°C.
Appearance
Lyophilized white powder
Shelf life
24 months unopened. 60 days reconstituted (refrigerated).
Listed CAS number
2381089-83-2

Follow the applicable batch documentation and your laboratory’s procedures. FirstLabs products are not supplied for personal dosing or treatment.

CUSTOMER REVIEWS

What researchers say

Loading reviews…

QUESTIONS

Frequently Asked About RETATRUTIDE

· YOU MAY ALSO LIKE ·

Related research compounds

RETATRUTIDE 10MG vialMETABOLIC RESEARCH

RETATRUTIDE

10MG

A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.

C$79.99
TIRZEPATIDE 10MG vialMETABOLIC RESEARCHOUT OF STOCK

TIRZEPATIDE

10MG

A dual GIP and GLP-1 receptor agonist used as a reference compound in laboratory metabolic research. Research interest includes incretin-pathway studies, energy-balance research, glycemic-marker research models, and gastric-motility research. For laboratory research use only.

C$60.01SOLD OUT
ELORALINTIDE 10MG vialMETABOLIC RESEARCH

ELORALINTIDE

10MG

A next-generation, receptor-selective amylin agonist designed to deliver the appetite suppression and weight-loss benefits of Cagrilintide while reducing nausea and other GI side effects through more targeted receptor activation. Research interest includes early-satiety signaling, powerful appetite suppression, lean mass preservation (in animal studies), minimal CTR activation for reduced GI side effects, and potential combination research with Tirzepatide (studies ongoing). For laboratory research use only.

C$140.00
AOD-9604 5MG vialMETABOLIC RESEARCH

AOD-9604

5MG

A modified fragment of human growth hormone (hGH 176-191). Research interest includes lipolysis-pathway studies, lipid-metabolism research models, and cartilage research. For laboratory research use only.

C$60.01
EARN WITH FIRSTLABSPH

Up to 30% commission. Paid monthly.

Join the FirstLabsPH partner program — built for researchers, educators, and creators who recommend independently verified peptides. Real-time dashboard, lifetime referral attribution, and on-time payouts.

10%
STARTER
20%
GROWTH
30%
ELITE